Biotech Management & Consulting
ActiveSummary
Biotech Management & Consulting has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €10,000 and a net result of €109,454. Equity has been shrinking by about 26% per year since 2020. If that trend continues, it turns negative around financial year 2027. Its solvency ranks better than 14% of 39,275 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 16-01-2020 Normal situation
- Activity
- Business and other management consultancy NACE 70200and 2 others
- Establishment unit
- 2.298.394.610 4458 Juprelle, since 16-01-2020
- Financial year end
- 31 December
- Peppol
- Reachable since 07-10-2025
Board and ownership
- Wallemacq HuguesDirector · since 16-01-2020
- Edith CHARLIERDirector · since 01-04-2024
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.1%
- Gross margin
- €158,505
- ▼ 21.3%
- Turnover
- ≈ €270,000
- estimated
- Profit
- €109,454
- ▼ 17.5%
- Equity
- €10,000
- =
- Total assets
- €147,789
- ▼ 47.0%
- Employees on 31-12-2025
- 0
Score breakdownraises riskEquity €10,000 (6.8% of total assets)lowers riskSector: Activities of head offices; management consultancy activities (NACE 70)Size: total assets €147,789Liquidity: current ratio 0.96, cash €78,500, halvedShow the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 70, micro). It does better than 14% of them on solvency, 33% on liquidity, 84% on profitability and 40% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 6 accounts on average 103 days before the deadline. In the sector (NACE 70), the median for financial year 2024 was 9 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
Key points
Recent changes
- · Gazette deed Appointment: Edith CHARLIER (director)
- · Gazette deed Resignation: Edith CHARLIER (director)
- · Gazette deed Appointment: Edith CHARLIER (director)
Comparable companies
These companies have the same main activity as Biotech Management & Consulting: business and other management consultancy (NACE 70200). They are comparable in size and age: total assets between €129,000 and €172,000, founded between 2019 and 2020.
| Company | Total assets | Gross margin |
|---|---|---|
| Biotech Management & Consulting Juprelle | €147,789 | €158,505 |
| JOCAFIN Chaudfontaine | €145,243 | €144,605 |
| VLM GESTION Liège | €171,654 | €176,967 |
| BRH CONSEIL Verviers | €138,813 | €165,368 |
| FLY Management Aywaille | €152,413 | €169,605 |
| PRAUXILIUM Wanze | €129,083 | €137,708 |
| FG PATRIMOINE Neupré | €138,082 | €138,186 |
Key facts about Biotech Management & Consulting
- What is the company number of Biotech Management & Consulting?
- The company number of Biotech Management & Consulting is 0741.644.479. The VAT number is the same number with BE in front: BE 0741.644.479.
- Where is Biotech Management & Consulting based?
- The registered office is at Rue Neuve 31, 4458 Juprelle.Company details
- What does Biotech Management & Consulting do?
- According to the KBO register, the main activity is business and other management consultancy (NACE 70200).
- What is the legal form of Biotech Management & Consulting?
- The legal form of Biotech Management & Consulting is Private limited company (BV).
- When was Biotech Management & Consulting founded?
- Biotech Management & Consulting was founded on 16-01-2020.
- Is Biotech Management & Consulting still active?
- Yes, Biotech Management & Consulting is an active enterprise in the KBO register.
- What is the turnover of Biotech Management & Consulting?
- The turnover in financial year 2025 is ≈ €270,000. This figure is estimated from the gross margin of €158,505 and 110 comparable companies (NACE 70200). It probably lies between €230,000 and €320,000. In financial year 2023 turnover was €0.Financials
- Is Biotech Management & Consulting profitable?
- In financial year 2025, Biotech Management & Consulting made a profit of €109,454.
- Where can I find the annual accounts of Biotech Management & Consulting?
- Biotech Management & Consulting filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Biotech Management & Consulting due?
- Biotech Management & Consulting must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.